{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:12:48Z","timestamp":1790691168568,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/nrgastro.2017.172","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:59:10Z","timestamp":1516150750000},"page":"283-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Extrahepatic cancers and chronic HCV infection"],"prefix":"10.1038","volume":"15","author":[{"given":"Stanislas","family":"Pol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Vallet-Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"BFnrgastro2017172_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.annepidem.2014.11.016","volume":"25","author":"D Schottenfeld","year":"2015","unstructured":"Schottenfeld, D. & Beebe-Dimmer, J. The cancer burden attributable to biologic agents. Ann. Epidemiol. 25, 183\u2013187 (2015). This is a general review detailing the link between cancer and microorganisms.","journal-title":"Ann. Epidemiol."},{"key":"BFnrgastro2017172_CR2","first-page":"1134","volume":"25","author":"F Bertoni","year":"2011","unstructured":"Bertoni, F. et al. MALT lymphomas: pathogenesis can drive treatment. Oncology 25, 1134\u20131142 (2011).","journal-title":"Oncology"},{"key":"BFnrgastro2017172_CR3","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1038\/sj.onc.1209559","volume":"25","author":"D Kremsdorf","year":"2006","unstructured":"Kremsdorf, D. & Soussan, P. & Paterlini-Brechot, P. & Brechot, P. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 25, 3823\u20133833 (2006).","journal-title":"Oncogene"},{"key":"BFnrgastro2017172_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young, L. S. & Rickinson, A. B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4, 757\u2013768 (2004).","journal-title":"Nat. Rev. Cancer."},{"key":"BFnrgastro2017172_CR5","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/v2092037","volume":"2","author":"P Kannian","year":"2010","unstructured":"Kannian, P. & Green, P. L. Human T lymphotropic virus type 1 (HTLV-1): Molecular biology and oncogenesis. Viruses 2, 2037\u20132077 (2010).","journal-title":"Viruses"},{"key":"BFnrgastro2017172_CR6","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/v6104047","volume":"6","author":"A Morales-S\u00e1nchez","year":"2014","unstructured":"Morales-S\u00e1nchez, A. & Fuentes-Panan\u00e1, E. M. Human viruses and cancer. Viruses 6, 4047\u20134079 (2014).","journal-title":"Viruses"},{"key":"BFnrgastro2017172_CR7","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1038\/sj.onc.1202867","volume":"18","author":"H Sirma","year":"1999","unstructured":"Sirma, H. et al. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene. 18, 4848\u20134859 (1999).","journal-title":"Oncogene."},{"key":"BFnrgastro2017172_CR8","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/JVI.72.4.3060-3065.1998","volume":"72","author":"J Chang","year":"1998","unstructured":"Chang, J. et al. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72, 3060\u20133065 (1998).","journal-title":"J. Virol."},{"key":"BFnrgastro2017172_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/2053","volume":"4","author":"K Moriya","year":"1998","unstructured":"Moriya, K. et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4, 1065\u20131067 (1998).","journal-title":"Nat. Med."},{"key":"BFnrgastro2017172_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(95)90400-X","volume":"345","author":"MS De Mitri","year":"1995","unstructured":"De Mitri, M. S. et al. HCV-associated liver cancer without cirrhosis. Lancet 345, 413\u2013415 (1995).","journal-title":"Lancet"},{"key":"BFnrgastro2017172_CR11","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/jnci\/92.18.1522","volume":"92","author":"H Hjalgrim","year":"2000","unstructured":"Hjalgrim, H. et al. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J. Natl Cancer Inst. 92, 1522\u20131528 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2017172_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1464-410X.2010.09622.x","volume":"107","author":"S Salem","year":"2011","unstructured":"Salem, S. et al. Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU Int. 107, 206\u2013211 (2011).","journal-title":"BJU Int."},{"key":"BFnrgastro2017172_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4251\/wjgo.v5.i7.132","volume":"5","author":"MA Suarez-Munoz","year":"2013","unstructured":"Suarez-Munoz, M. A. et al. Risk factors and classifications of hilar cholangiocarcinoma. World J. Gastrointest. Oncol. 5, 132\u2013138 (2013).","journal-title":"World J. Gastrointest. Oncol."},{"key":"BFnrgastro2017172_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2141.1995.tb05582.x","volume":"90","author":"F Franzin","year":"1995","unstructured":"Franzin, F. et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br. J. Haematol. 90, 548\u2013552 (1995).","journal-title":"Br. J. Haematol."},{"key":"BFnrgastro2017172_CR15","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","volume":"111","author":"ED Charles","year":"2008","unstructured":"Charles, E. D. et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 111, 1344\u20131356 (2008).","journal-title":"Blood"},{"key":"BFnrgastro2017172_CR16","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3748\/wjg.15.1636","volume":"15","author":"HB Fan","year":"2009","unstructured":"Fan, H. B. et al. B-Cell clonality in the liver of hepatitis C virus-infected patients. World J. Gastroenterol. 15, 1636\u20131640 (2009).","journal-title":"World J. Gastroenterol."},{"issue":"Suppl. 1","key":"BFnrgastro2017172_CR17","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/cyto.b.20545","volume":"78","author":"C Fazi","year":"2010","unstructured":"Fazi, C. et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin. Cytom. 78 (Suppl. 1), S61\u2013S68 (2010).","journal-title":"Cytometry B Clin. Cytom."},{"key":"BFnrgastro2017172_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/1097-0142(19890401)63:7<1251::AID-CNCR2820630704>3.0.CO;2-H","volume":"63","author":"F Ben Ayed","year":"1989","unstructured":"Ben Ayed, F. et al. Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group. Cancer 63, 1251\u20131256 (1989).","journal-title":"Cancer"},{"key":"BFnrgastro2017172_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2169\/internalmedicine.35.961","volume":"35","author":"S Matsumoto","year":"1996","unstructured":"Matsumoto, S. et al. \u201cMediterranean lymphoma\u201d treated with antibiotics. Intern. Med. 35, 961\u2013965 (1996).","journal-title":"Intern. Med."},{"key":"BFnrgastro2017172_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit, M. et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350, 239\u2013248 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017172_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard, T. & Bedossa, P. & Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349, 825\u2013832 (1997).","journal-title":"Lancet"},{"key":"BFnrgastro2017172_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.autrev.2016.09.006","volume":"15","author":"C Ferri","year":"2016","unstructured":"Ferri, C. et al. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun. Rev. 15, 1145\u20131160 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFnrgastro2017172_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"MH Lee","year":"2012","unstructured":"Lee, M. H. et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J. Infect. Dis. 206, 469\u2013477 (2012).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2017172_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","volume":"46","author":"D Saadoun","year":"2007","unstructured":"Saadoun, D. et al. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology 46, 1234\u20131242 (2007).","journal-title":"Rheumatology"},{"key":"BFnrgastro2017172_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/1471-2407-11-495","volume":"11","author":"FH Su","year":"2011","unstructured":"Su, F. H. et al. Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. BMC Cancer. 11, 495 (2011).","journal-title":"BMC Cancer."},{"key":"BFnrgastro2017172_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","volume":"6","author":"S de Sanjose","year":"2008","unstructured":"de Sanjose, S. et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin. Gastroenterol. Hepatol. 6, 451\u2013458 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2017172_CR27","doi-asserted-by":"publisher","first-page":"S220","DOI":"10.1016\/S0168-8278(15)30072-6","volume":"62","author":"AH Nyberg","year":"2015","unstructured":"Nyberg, A. H. et al. Increased cancer rates in patients with chronic hepatitis C: an analysis of the cancer registry in a large US health maintenance organization. J. Hepatol. 62, S220 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2017172_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","volume":"63","author":"RD Allison","year":"2015","unstructured":"Allison, R. D. et al. Chronic Hepatitis Cohort Study (CHeCS) Investigators. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010. J. Hepatol. 63, 822\u2013828 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2017172_CR29","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.3748\/wjg.v21.i45.12896","volume":"21","author":"S Fiorino","year":"2015","unstructured":"Fiorino, S. et al. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: a systematic review. World J. Gastroenterol. 21, 12896\u201312953 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2017172_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/cncr.30559","volume":"123","author":"P Mahale","year":"2017","unstructured":"Mahale, P. et al. Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study. Cancer 123, 1202\u20131211 (2017). This is a registry study evidencing the higher risk of hepatic and extrahepatic cancers in populations infected with HCV than in non-HCV-infected populations.","journal-title":"Cancer"},{"key":"BFnrgastro2017172_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ijc.20021","volume":"1","author":"EA Engels","year":"2004","unstructured":"Engels, E. A. et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int. J. Cancer. 1, 76\u201380 (2004).","journal-title":"Int. J. Cancer."},{"key":"BFnrgastro2017172_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ijc.20137","volume":"3","author":"R Talamini","year":"2004","unstructured":"Talamini, R. et al. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int. J. Cancer. 3, 380\u2013385 (2004).","journal-title":"Int. J. Cancer."},{"key":"BFnrgastro2017172_CR33","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","volume":"6","author":"JP Gisbert","year":"2003","unstructured":"Gisbert, J. P. et al. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 6, 1723\u20131732 (2003). This is a meta-analysis evidencing the higher prevalence of NHL in HCV infection.","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017172_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4254\/wjh.v8.i2.107","volume":"8","author":"G Pozzato","year":"2016","unstructured":"Pozzato, G. et al. Hepatitis C virus and non-Hodgkin's lymphomas: meta-analysis of epidemiology data and therapy options. World J. Hepatol. 8, 107\u2013116 (2016).","journal-title":"World J. Hepatol."},{"key":"BFnrgastro2017172_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1023\/A:1008255830453","volume":"5","author":"M Luppi","year":"1998","unstructured":"Luppi, M. et al. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann. Oncol. 5, 495\u2013498 (1998).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro2017172_CR36","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","volume":"6","author":"C Besson","year":"2006","unstructured":"Besson, C. et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in NHL 93 and NHL 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J. Clin. Oncol. 6, 953\u2013960 (2006).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2017172_CR37","doi-asserted-by":"publisher","first-page":"e0162965","DOI":"10.1371\/journal.pone.0162965","volume":"11","author":"L Alric","year":"2016","unstructured":"Alric, L. et al. Antiviral treatment of HVC-infected patients with B-cell non-hodgkin lymphoma: ANRS HC-13 Lympho-C study. PLoS ONE 11, e0162965 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2017172_CR38","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","volume":"6","author":"A Nieters","year":"2006","unstructured":"Nieters, A. et al. Hepatitis C and risk of lymphoma: results of the European multicenter cases control study EPILYMPH. Gastroenterology 6, 1879\u20131886 (2006). This is a European multicentre study describing the characteristics of lymphoma associated with HCV infection.","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017172_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","volume":"59","author":"J Peveling-Oberhag","year":"2013","unstructured":"Peveling-Oberhag, J. et al. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J. Hepatol. 59, 169\u2013177 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2017172_CR40","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","volume":"107","author":"F Suarez","year":"2006","unstructured":"Suarez, F. et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107, 3034\u20133044 (2006).","journal-title":"Blood"},{"issue":"Suppl. 1","key":"BFnrgastro2017172_CR41","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S1590-8658(07)80008-9","volume":"39","author":"F Suarez","year":"2007","unstructured":"Suarez, F. et al. Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis. Dig. Liver Dis. 39 (Suppl. 1), S32\u2013S37 (2007). This is a comprehensive review of the pathobiology of lymphoma associated with HCV infection.","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2017172_CR42","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.0303971101","volume":"101","author":"K Machida","year":"2004","unstructured":"Machida, K. et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc. Natl Acad. Sci. USA 101, 4262\u20134267 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017172_CR43","doi-asserted-by":"publisher","first-page":"12590","DOI":"10.1128\/JVI.02643-08","volume":"83","author":"K Machida","year":"2009","unstructured":"Machida, K. et al. Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J. Virol. 83, 12590\u201312600 (2009).","journal-title":"J. Virol."},{"key":"BFnrgastro2017172_CR44","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.1128\/JVI.78.16.8835-8843.2004","volume":"16","author":"K Machida","year":"2004","unstructured":"Machida, K. et al. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J. Virol. 16, 8835\u20138843 (2004).","journal-title":"J. Virol."},{"key":"BFnrgastro2017172_CR45","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.4049\/jimmunol.1000618","volume":"11","author":"K Machida","year":"2010","unstructured":"Machida, K. et al. Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1\/Mre11\/Rad50 DNA repair pathway in monocytes and hepatocytes. J. Immunol. 11, 6985\u20136998 (2010).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017172_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2249.1994.tb06584.x","volume":"97","author":"A Gabrielli","year":"1994","unstructured":"Gabrielli, A. et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin. Exp. Immunol. 97, 87\u201393 (1994).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrgastro2017172_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2249.2006.03272.x","volume":"147","author":"D Sansonno","year":"2007","unstructured":"Sansonno, D. et al. Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia. Clin. Exp. Immunol. 147, 241\u2013248 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrgastro2017172_CR48","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938\u2013941 (1998).","journal-title":"Science"},{"key":"BFnrgastro2017172_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ajh.20092","volume":"76","author":"S Paydas","year":"2004","unstructured":"Paydas, S. et al. Detection of hepatitis C virus RNA in paraffin-embedded tissues from patients with non-Hodgkin Lymphoma. Am. J. Hematol. 76, 252\u2013257 (2004).","journal-title":"Am. J. Hematol."},{"key":"BFnrgastro2017172_CR50","doi-asserted-by":"crossref","first-page":"717951","DOI":"10.1155\/2011\/717951","volume":"2011","author":"Y Tsutsumi","year":"2011","unstructured":"Tsutsumi, Y. et al. HCV virus and Lymphoid neoplasms. Adv. Hematol. 2011, 717951 (2011).","journal-title":"Adv. Hematol."},{"key":"BFnrgastro2017172_CR51","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.humpath.2005.06.005","volume":"8","author":"M Takeshita","year":"2005","unstructured":"Takeshita, M. et al. Splenic large B cell lymphoma in patients with Hepatitis C virus infection. Hum. Pathol. 8, 878\u2013885 (2005).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro2017172_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2559.2005.02311.x","volume":"2","author":"M Takeshita","year":"2006","unstructured":"Takeshita, M. et al. Prevalence of hepatitis C virus infection in cases of B cell lymphoma in Japan. Histopathology 2, 189\u2013198 (2006).","journal-title":"Histopathology"},{"key":"BFnrgastro2017172_CR53","doi-asserted-by":"publisher","first-page":"e0156384","DOI":"10.1371\/journal.pone.0156384","volume":"11","author":"D Canioni","year":"2016","unstructured":"Canioni, D. et al. In situ hepatitis C NS3 protein detection is associated with high grade features in hepatitis C-associated B-cell non-Hodgkin lymphomas. PLoS ONE 11, e0156384 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2017172_CR54","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1365-2141.2001.02573.x","volume":"112","author":"E Zuckerman","year":"2001","unstructured":"Zuckerman, E. et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br. J. Haematol. 112, 364\u2013369 (2001).","journal-title":"Br. J. Haematol."},{"key":"BFnrgastro2017172_CR55","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","volume":"116","author":"D Ennishi","year":"2010","unstructured":"Ennishi, D. et al. Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 116, 5119\u20135125 (2010).","journal-title":"Blood"},{"key":"BFnrgastro2017172_CR56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.21564","volume":"1","author":"L Arcaini","year":"2010","unstructured":"Arcaini, L. et al. Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. Am. J. Hematol. 1, 46\u201350 (2010).","journal-title":"Am. J. Hematol."},{"key":"BFnrgastro2017172_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine, O. et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347, 89\u201394 (2002). This study provides the first evidence that antiviral treatment of HCV could result in lymphoma remission.","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017172_CR58","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","volume":"23","author":"D Vallisa","year":"2005","unstructured":"Vallisa, D. et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J. Clin. Oncol. 23, 468\u2013473 (2005).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2017172_CR59","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.amjmed.2007.06.022","volume":"120","author":"Y Kawamura","year":"2007","unstructured":"Kawamura, Y. et al. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am. J. Med. 120, 1034\u20131041 (2007).","journal-title":"Am. J. Med."},{"key":"BFnrgastro2017172_CR60","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","volume":"25","author":"L Arcaini","year":"2014","unstructured":"Arcaini, L. et al. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann. Oncol. 25, 1404\u20131410 (2014).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro2017172_CR61","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ajh.23889","volume":"90","author":"JM Michot","year":"2015","unstructured":"Michot, J. M. et al. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. Am. J. Hematol. 90, 197\u2013203 (2015).","journal-title":"Am. J. Hematol."},{"key":"BFnrgastro2017172_CR62","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. J. Hepatol. 66, 153\u2013194 (2016).","DOI":"10.1016\/j.jhep.2016.09.001"},{"key":"BFnrgastro2017172_CR63","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1111\/liv.12897","volume":"35","author":"P Carrier","year":"2015","unstructured":"Carrier, P. et al. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents. Liver Int. 35, 2222\u20132227 (2015).","journal-title":"Liver Int."},{"key":"BFnrgastro2017172_CR64","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jhep.2014.09.031","volume":"62","author":"R Rossotti","year":"2015","unstructured":"Rossotti, R. et al. Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3\/NS4A inhibitor-based treatment. A case report. J. Hepatol. 62, 234\u2013237 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2017172_CR65","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1182\/blood-2014-12-618652","volume":"125","author":"P Sultanik","year":"2015","unstructured":"Sultanik, P. et al. Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment. Blood 125, 2446\u20132447 (2015).","journal-title":"Blood"},{"key":"BFnrgastro2017172_CR66","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood-2016-05-714667","volume":"128","author":"L Arcaini","year":"2016","unstructured":"Arcaini, L. et al. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood 128, 2527\u20132532 (2016).","journal-title":"Blood"},{"key":"BFnrgastro2017172_CR67","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson, B. D. et al. Recommendations for initial evaluation, staging, and response assessment in Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J. Clin. Oncol. 32, 3059\u20133068 (2014).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2017172_CR68","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.28753","volume":"64","author":"L Gragnani","year":"2016","unstructured":"Gragnani, L. et al. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology 64, 1473\u20131482 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2017172_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13075-017-1280-6","volume":"19","author":"G Lauletta","year":"2017","unstructured":"Lauletta, G. et al. Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience. Arthritis Res. Ther. 19, 74 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrgastro2017172_CR70","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","volume":"65","author":"M Reig","year":"2016","unstructured":"Reig, M. et al. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J. Hepatol. 65, 719\u2013726 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2017172_CR71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0009-9120(01)00210-7","volume":"34","author":"PM Jacobson Brown","year":"2001","unstructured":"Jacobson Brown, P. M. & Neuman, M. G. Immunopathogenesis of hepatitis C viral infection: Th1\/Th2 responses and the role of cytokines. Clin. Biochem. 34, 167\u2013171 (2001). This paper provides a clear demonstration that chronic HCV infection is associated with immunological impairment, including T cell dysregulation.","journal-title":"Clin. Biochem."},{"key":"BFnrgastro2017172_CR72","doi-asserted-by":"publisher","first-page":"e07916","DOI":"10.7554\/eLife.07916","volume":"4","author":"C Alanio","year":"2015","unstructured":"Alanio, C. et al. Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients. eLife. 4, e07916 (2015).","journal-title":"eLife."},{"key":"BFnrgastro2017172_CR73","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1172\/JCI75938","volume":"124","author":"EG Meissner","year":"2014","unstructured":"Meissner, E. G. et al. Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J. Clin. Invest. 124, 3352\u20133363 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017172_CR74","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3748\/wjg.v6.i6.805","volume":"6","author":"FM Yan","year":"2000","unstructured":"Yan, F. M. et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J. Gastroenterol. 6, 805\u2013811 (2000).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2017172_CR75","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/hep.510280531","volume":"28","author":"T Laskus","year":"1998","unstructured":"Laskus, T. et al. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology 28, 1398\u20131401 (1998).","journal-title":"Hepatology"},{"key":"BFnrgastro2017172_CR76","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","volume":"142","author":"NF Fletcher","year":"2012","unstructured":"Fletcher, N. F. et al. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142, 634\u2013643 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017172_CR77","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","volume":"7","author":"C Ferri","year":"2015","unstructured":"Ferri, C. et al. Hepatitis C virus syndrome: a constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer. World J. Hepatol. 7, 327\u2013343 (2015).","journal-title":"World J. Hepatol."},{"key":"BFnrgastro2017172_CR78","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1186\/s12885-016-2918-5","volume":"16","author":"AB Kamiza","year":"2016","unstructured":"Kamiza, A. B. et al. Chronic hepatitis infection is associated with extrahepatic cancer development: a nationwide population-based study in Taiwan. BMC Cancer 16, 861 (2016).","journal-title":"BMC Cancer"},{"key":"BFnrgastro2017172_CR79","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1158\/1055-9965.EPI-15-1115","volume":"25","author":"S Krull Abe","year":"2016","unstructured":"Krull Abe, S. et al. JPHC Study Group. Hepatitis B and C Virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC Study Cohort II). Cancer Epidemiol. Biomarkers Prev. 25, 555\u2013557 (2016).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"Suppl. 5","key":"BFnrgastro2017172_CR80","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","volume":"46","author":"P Cacoub","year":"2014","unstructured":"Cacoub, P. et al. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig. Liver Dis. 46 (Suppl. 5), S165\u2013S173 (2014).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2017172_CR81","doi-asserted-by":"publisher","first-page":"e81305","DOI":"10.1371\/journal.pone.0081305","volume":"8","author":"H Huang","year":"2013","unstructured":"Huang, H. & Kang, R. & Zhao, Z. Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS ONE. 8, e81305 (2013).","journal-title":"PLoS ONE."},{"key":"BFnrgastro2017172_CR82","doi-asserted-by":"publisher","first-page":"11974","DOI":"10.3748\/wjg.v21.i42.11974","volume":"21","author":"S Monaco","year":"2015","unstructured":"Monaco, S. et al. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World J. Gastroenterol. 21, 11974\u201311983 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2017172_CR83","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","volume":"149","author":"F Negro","year":"2015","unstructured":"Negro, F. et al. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology 149, 1345\u20131360 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017172_CR84","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/hep.26087","volume":"57","author":"Y Arase","year":"2013","unstructured":"Arase, Y. et al. Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology 57, 964\u2013973 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro2017172_CR85","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","volume":"152","author":"P Nahon","year":"2016","unstructured":"Nahon, P. et al. Eradication of Hepatitis C Virus infection in patients with cirrhosis reduces risk of liver and non-liver complications; ANRS CO12 CirVir Group. Gastroenterology 152, 142\u2013156.e2 (2016).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017172_CR86","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12957-015-0583-9","volume":"13","author":"LH Li","year":"2015","unstructured":"Li, L. H. et al. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma an extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J. Surg. Oncol. 13, 161 (2015).","journal-title":"World J. Surg. Oncol."},{"key":"BFnrgastro2017172_CR87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","volume":"57","author":"WC Palmer","year":"2012","unstructured":"Palmer, W. C. & Patel, T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J. Hepatol. 57, 69\u201376 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2017172_CR88","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/hep.510280404","volume":"28","author":"HT Sorensen","year":"1998","unstructured":"Sorensen, H. T. et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28, 921\u2013925 (1998).","journal-title":"Hepatology"},{"key":"BFnrgastro2017172_CR89","unstructured":"AASLD & IDSA. HCV guidance: recommendations for testing, managing, and treating hepatitis C. http:\/\/www.hcvguidelines.org (2017)."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.172","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrgastro.2017.172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:01:09Z","timestamp":1719745269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2017.172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["BFnrgastro2017172"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2017.172","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"17 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}